Marquita Anderson, MD
Obstetrics · Mansfield, TXNPI 1922323864
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations.
Across 90 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$212
- Biogen$193
- Pfizer$149
- Mayne Pharma Commercial LLC$129
- Sanofi$123
- Agile Therapeutics, Inc.$122
- plus $963 from 20 others
Across 223 payments — averaging $15,017 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.7M
- GSK$289K
- Modernatx, Inc.$124K
- Sumitomo Pharma America, Inc.$87K
- Myovant Sciences GmbH$56K
- Organon$45K
- plus $43K from 3 others
What the payments were for
- Food & beverage$1,891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $212 |
| Biogen | 10 | $193 |
| Pfizer | 11 | $149 |
| Mayne Pharma Commercial LLC | 4 | $129 |
| Sanofi | 1 | $123 |
| Agile Therapeutics, Inc. | 7 | $122 |
| Novo Nordisk | 2 | $121 |
| Hologic Sales And Service, LLC | 3 | $109 |
| Myriad Women's Health, Inc. | 2 | $102 |
| Organon | 5 | $89 |
| Shield Therapeutics Inc | 3 | $83 |
| Exeltis, USA Inc. | 4 | $74 |
| Astellas Pharma US Inc | 4 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Innovation Technologies Inc | 2 | $48 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Coopersurgical, Inc. | 2 | $29 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Bayer | 1 | $19 |
| Minerva Surgical, Inc | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Mycovia Pharmaceuticals, Inc. | 1 | $18 |
| Conmed Corporation | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $13 |
| Baxter Healthcare | 1 | $12 |
How this compares
$1,891 in reported general payments places this provider in the 60th percentile of 85 obstetrics providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics in Mansfield
- Hearther DaleyMcAllen$57K
- Sara MoufarrijHouston$52K
- Rene PerezSan Antonio$20K
- Lisa BourbeauAustin$11K
- Heather NevilleFort Worth$10K
- Erica GarzaAustin$9K
- Vagisha SharmaArlington$9K
- Liliana KanuPasadena$9K
- Laura FonsecaMcAllen$8K
- Caroline CohenAustin$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.